AKT1 and central nervous system cancer: It was hypothesized that eckol may enhance the sensitivity of glioma stem-like cells to anticancer treatments such as ionizing radiation or chemical drugs via inhibition of PI3K-Akt and Ras-Raf-1-Erk pathways.